» Authors » Heinz-Josef Schmitt

Heinz-Josef Schmitt

Explore the profile of Heinz-Josef Schmitt including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 42
Citations 1063
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nacov J, Stemler J, Salmanton-Garcia J, Cremer L, Zeitlinger M, Mallon P, et al.
Infection . 2024 May; 52(4):1563-1574. PMID: 38806974
Purpose: Considering the re-emergence of poliomyelitis (PM) in non-endemic regions, it becomes apparent that vaccine preventable diseases can rapidly develop epi- or even pandemic potential. Evaluation of the current vaccination...
2.
Pilz A, Erber W, Schmitt H
Ticks Tick Borne Dis . 2022 Nov; 14(1):102059. PMID: 36410164
Vaccination as a highly effective measure to protect against tick-borne encephalitis (TBE) comes into new focus as known risk areas are expanding across Europe and Asia. Here we present an...
3.
Steffen R, Schmitt H, Zavadska D
J Travel Med . 2022 Mar; 29(2). PMID: 35238909
No abstract available.
4.
Erber W, Khan F, Zavadska D, Freimane Z, Dobler G, Bohmer M, et al.
Vaccine . 2021 Dec; 40(5):819-825. PMID: 34952753
Background: Tick-borne encephalitis (TBE) is a vaccine-preventable disease which may cause long-term sequelae and even death. The data on the long-term effectiveness of TBE vaccines are limited. Additionally, the vaccination...
5.
McLaughlin J, Khan F, Schmitt H, Agosti Y, Jodar L, Simoes E, et al.
J Infect Dis . 2020 Dec; 225(6):1100-1111. PMID: 33346360
Background: Although global reviews of infant respiratory syncytial virus (RSV) burden exist, none have summarized data from the United States or evaluated how RSV burden estimates are influenced by variations...
6.
McLaughlin J, Khan F, Pugh S, Angulo F, Schmitt H, Isturiz R, et al.
Clin Infect Dis . 2020 Nov; 73(7):e1814-e1821. PMID: 33211797
Background: The United States has been heavily impacted by the coronavirus disease 2019 (COVID-19) pandemic. Understanding microlevel patterns in US rates of COVID-19 can inform specific prevention strategies. Methods: Using...
7.
Htar M, Morato Martinez J, Theilacker C, Schmitt H, Swerdlow D
Expert Rev Vaccines . 2019 Nov; 18(11):1145-1155. PMID: 31682762
: Epidemiologic trends for IPD have evolved with the introduction of pneumococcal conjugate vaccines into childhood immunization programs. We document the ongoing impact of PCV programs in 15 Western European...
8.
Htar M, Sings H, Syrochkina M, Taysi B, Hilton B, Schmitt H, et al.
Expert Rev Vaccines . 2019 Oct; 18(12):1243-1270. PMID: 31587592
: By preventing nasopharyngeal carriage acquisition among vaccinated persons, and thus reducing transmission, pneumococcal conjugate vaccines (PCVs) provide protection against pneumococcal vaccine serotypes among unvaccinated individuals. This systematic review assessed...
9.
Htar M, van den Biggelaar A, Sings H, Ferreira G, Moffatt M, Hall-Murray C, et al.
Expert Rev Vaccines . 2019 Oct; 18(10):1069-1089. PMID: 31585049
: The introduction of 7-valent pneumococcal conjugate vaccine (PCV7) in childhood immunization programs reduced antimicrobial-resistant pneumococcal infections by vaccine serotypes. However, emerging antimicrobial-resistant non-vaccine serotypes, particularly serotype 19A, attenuated the...
10.
Zavadska D, Odzelevica Z, Karelis G, Liepina L, Litauniece Z, Bormane A, et al.
PLoS One . 2018 Nov; 13(11):e0204844. PMID: 30422984
Background: The incidence of tick-borne encephalitis (TBE) varies significantly over time. To better understand the annual incidence of all TBE cases in Latvia we investigated the disease burden in the...